CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice

The antagonism of CXC-chemokine receptor 4 (CXCR4) with AMD3100 improves cardiac performance after myocardial infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow to the regenerating vasculature. We investigated whether AMD3100 may accelerate diabetes-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Yukihide, Ii, Masaaki, Qin, Gangjian, Hamada, Hiromichi, Asai, Jun, Takenaka, Hideya, Sekiguchi, Haruki, Renault, Marie-Ange, Jujo, Kentaro, Katoh, Norito, Kishimoto, Saburo, Ito, Aiko, Kamide, Christine, Kenny, John, Millay, Meredith, Misener, Sol, Thorne, Tina, Losordo, Douglas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276738/
https://www.ncbi.nlm.nih.gov/pubmed/22048734
http://dx.doi.org/10.1038/jid.2011.356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276738/
https://www.ncbi.nlm.nih.gov/pubmed/22048734
http://dx.doi.org/10.1038/jid.2011.356

Ejemplares similares